Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).

被引：2
|
作者：
Hirose, T. [1 ]
Shirai, T. [1 ]
Kusumoto, S. [1 ]
Sugiyama, T. [1 ]
Yamaoka, T. [1 ]
Okuda, K. [1 ]
Ohmori, T. [1 ]
Ohnishi, T. [1 ]
Adachi, M. [1 ]
机构：
[1] Showa Univ, Sch Med, Tokyo 142, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
    Hirose, Takashi
    Nakashima, Masanao
    Shirai, Takao
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Ohnishi, Tsukasa
    Ohmori, Tohru
    Adachi, Mitsuru
    LUNG CANCER, 2011, 73 (03) : 345 - 350
  • [2] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR REFRACTORY RELAPSED SMALL CELL LUNG CANCER (SCLC): NORTH JAPAN LUNG CANCER GROUP 0802
    Oizumi, S.
    Inoue, A.
    Sakakibara, T.
    Asahina, H.
    Sugawara, S.
    Maemondo, M.
    Okudera, K.
    Suzuki, T.
    Usui, K.
    Harada, M.
    Morikawa, N.
    Hasegawa, Y.
    Ishimoto, O.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 105 - 105
  • [3] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Small Cell Lung Cancer
    Yoshioka, Hiroshige
    Kogure, Yoshihito
    Ando, Masahiko
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Niwa, Takashi
    Saka, Hideo
    IN VIVO, 2018, 32 (06): : 1581 - 1586
  • [4] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)
    Han, J.
    Lim, K. Y.
    Kim, H. Y.
    Han, J. H.
    Oh, S. H.
    Yun, T.
    Kim, H. T.
    Lee, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.
    Saito, Ryota
    Inoue, Akira
    Sugawara, Shunichi
    Oizumi, Satoshi
    Maemondo, Makoto
    Okudera, Koichi
    Suzuki, Toshiro
    Usui, Kazuhiro
    Harada, Masao
    Morikawa, Naoto
    Hasegawa, YUkihiro
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Asahina, Hajime
    Nukiwa, Toshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer
    Hirose, T
    Horichi, N
    Ohmori, T
    Ogura, K
    Hosaka, T
    Ando, K
    Ishida, H
    Noguchi, H
    Adachi, M
    LUNG CANCER, 2003, 40 (03) : 333 - 338
  • [7] PHASE II STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED NON-SMALL CELL LUNG CANCER
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Yoshioka, Hiroshige
    Kitagawa, Chiyoe
    Saka, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S875 - S875
  • [8] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer (SCLC)
    Pietanza, M. C.
    Sima, C. S.
    Polley, M. R.
    Sumner, D. K.
    Travis, V.
    Heguy, A.
    Ginsberg, M. S.
    Holodny, A.
    Kris, M. G.
    Krug, L. M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S507 - S507
  • [9] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    IN VIVO, 2019, 33 (01): : 163 - 166
  • [10] Final result of phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for elderly patients with small cell lung cancer (SCLC)
    Ishimoto, O.
    Inoue, A.
    Sugawara, S.
    Harada, M.
    Usui, K.
    Suzuki, T.
    Yokouchi, H.
    Maemondo, M.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345